Biosimilars in oncology and inflammatory diseases: current and future considerations for clinicians in Latin America

Biological therapies have revolutionized the treatment of several cancers and systemic immune-mediated inflammatory conditions. Expiry of patents protecting a number of biologics has provided the opportunity to commercialize highly similar versions, known as biosimilars. Biosimilars are approved by...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:MAbs
Egile Nagusiak: Scheinberg, Morton, Pineda, Carlos, Castañeda-Hernández, Gilberto, Zarbá, Juan José, Damião, Aderson, Arantes Jr, Luiz H, Jacobs, Ira
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2018
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6152448/
https://ncbi.nlm.nih.gov/pubmed/30156950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2018.1484977
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak